QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Nitrofurantoin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 1,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Norethindrone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 to 10 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Women’s Health |
| Classification: | Drug Assays |
Norgestimate
Norgestrel (Matrix: Human Plasma)
Norgestrel (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 50,000 pg/mL 20 – 20,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Women’s Health |
| Classification: | Drug Assays |
Nortriptyline
10-OH-Nortriptyline (Matrix: Human Plasma)
10-OH-Nortriptyline (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.18 – 50 ng/mL 0.3 – 80 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Olanzapine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.500 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Dementia and Alzheimer’s Disease |
| Classification: | Drug Assays |
Olmesartan (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10- 3,000 ng/mL |
| Sample Volume: | 0.1mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Olsalazine in presence of Mesalamine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 8 – 2,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiinflammatory |
| Classification: | Drug Assays |
Omeprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 2,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Gastrointestinal |
| Classification: | Drug Assays |
Omeprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 5,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Gastrointestinal |
| Classification: | Drug Assays |
Ondansetron (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiemetic |
| Classification: | Drug Assays |
Osimertinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.4 – 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Ospemifene (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 1 – 750 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Women’s Health |
| Classification: | Drug Assays |
Ospemifene
4-OH-Ospemifene4′-OH-Ospemifene (Matrix: Human Serum)
4-OH-Ospemifene4′-OH-Ospemifene (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 1 – 750 ng/mL 2 – 1,500 ng/mL2 – 1,500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Women’s Health |
| Classification: | Drug Assays |
Osteopontin (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 0.313 – 20.0 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Oxaliplatin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.00 – 1,000 ngPt/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Oxaliplatin (Matrix: Human Plasma Ultrafiltrate)
| Matrix: | Human Plasma Ultrafiltrate |
| Assay Range: | 3.00 – 1,000 ngPt/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Oxaliplatin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.00-1,000 ngPt/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Oxaliplatin (Matrix: Human Plasma Ultrafiltrate)
| Matrix: | Human Plasma Ultrafiltrate |
| Assay Range: | 3.00-1,000 ngPt/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | ICP-MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Oxazepam
Lorazepam (Matrix: Human Plasma)
Lorazepam (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 ng/mL 0.2 – 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | K2 EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Sedative |
| Classification: | Drug Assays |
Oxycodone
Noroxycodone
Oxymorphone (Matrix: Dog Plasma)
Noroxycodone
Oxymorphone (Matrix: Dog Plasma)
| Matrix: | Dog Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Oxycodone
Noroxycodone
Oxymorphone (Matrix: Human Plasma)
Noroxycodone
Oxymorphone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.2 – 100 ng/mL 0.2 – 100 ng/mL2 – 100 ng/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Oxycodone
Noroxycodone
Oxymorphone (Matrix: Rat Plasma)
Noroxycodone
Oxymorphone (Matrix: Rat Plasma)
| Matrix: | Rat Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Oxymorphone (Matrix: Dog Plasma)
| Matrix: | Dog Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Oxymorphone (Matrix: Mouse Plasma)
| Matrix: | Mouse Plasma |
| Assay Range: | 0.2 – 250 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
Oxymorphone (Matrix: Rabbit Plasma)
| Matrix: | Rabbit Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Narcotic Analgesic |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
